4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
My Health - My Data (MH-MD)
Date du début: 1 nov. 2016, Date de fin: 31 oct. 2019,
Issues of data subjects’ privacy and data security represent a crucial challenge in the biomedical sector more than in other industries. The current IT landscape in this field shows a myriad of isolated, locally hosted patient data repositories, managed by clinical centres and other organisations, which are subject to frequent and massive data breaches. Patients are disenfranchised in this process ...
Voir le projet
16
Participants partenaires
TERMINÉ
Personalised Decision Support for Heart Valve Disease (EurValve)
Date du début: 1 févr. 2016, Date de fin: 31 janv. 2019,
Valvular Heart Disease currently affects 2.5% of the population, but is overwhelmingly a disease of the elderly and consequently on the rise. It is dominated by two conditions, Aortic Stenosis and Mitral Regurgitation, both of which are associated with significant morbidity and mortality, yet which pose a truly demanding challenge for treatment optimisation. By combining multiple complex modelling ...
Voir le projet
14
Participants partenaires
TERMINÉ
Proof of Concept of Model-based Cardiovascular Prediction (CARDIOPROOF)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2016,
CARDIOPROOF is a proof-of-concept project that consolidates the outcomes of previous VPH projects and checks the applicability and effectiveness of available predictive modelling and simulation tools, validating them in interrelated clinical trials conducted in three European centres of excellence in cardiac treatment (from Germany, Italy and the UK). CARDIOPROOF focuses on patients with aortic va ...
Voir le projet
10
Participants partenaires
TERMINÉ
Living autologous heart valves for minimally invasive implantable procedures (LIFEVALVE)
Date du début: 1 nov. 2009, Date de fin: 30 avr. 2015,
Cardiovascular disease still represents the Killer No.1 in the EU accounting for substantial morbidity/mortality and health care cost. Heart valve replacement represents the most common surgical therapy for valvular heart disease with almost 200.000 annual implantations worldwide. Currently, heart valve prosthesis-associated problems occur in 30-35% of patients within 10 years, frequently necessit ...
Voir le projet